These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 21484794

  • 1. Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer.
    Park Y, Kim Y, Lee EY, Lee JH, Kim HS.
    Int J Cancer; 2012 Mar 01; 130(5):1136-44. PubMed ID: 21484794
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performances of CA125, HE4, and ROMA index in ovarian cancer.
    Dikmen ZG, Colak A, Dogan P, Tuncer S, Akbiyik F.
    Eur J Gynaecol Oncol; 2015 Mar 01; 36(4):457-62. PubMed ID: 26390703
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic measures comparison for ovarian malignancy risk in Epithelial ovarian cancer patients: a meta-analysis.
    Suri A, Perumal V, Ammalli P, Suryan V, Bansal SK.
    Sci Rep; 2021 Aug 27; 11(1):17308. PubMed ID: 34453074
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses.
    Anton C, Carvalho FM, Oliveira EI, Maciel GA, Baracat EC, Carvalho JP.
    Clinics (Sao Paulo); 2012 Aug 27; 67(5):437-41. PubMed ID: 22666786
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer.
    Leung F, Bernardini MQ, Brown MD, Zheng Y, Molina R, Bast RC, Davis G, Serra S, Diamandis EP, Kulasingam V.
    Cancer Epidemiol Biomarkers Prev; 2016 Sep 27; 25(9):1333-40. PubMed ID: 27448593
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic performance and establishment of reference limits of HE4 in Korean healthy women.
    Yu S, Lee JK, Kim JH, Park H, Lee MY, Ryu S, Kwon MJ, Woo HY.
    Gynecol Oncol; 2016 Oct 27; 143(1):128-134. PubMed ID: 27426308
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human epididymis protein 4 reference intervals in a multiethnic asian women population.
    Mokhtar N, Thevarajah M, Ma N, M I.
    Asian Pac J Cancer Prev; 2012 Oct 27; 13(12):6391-5. PubMed ID: 23464464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.